期刊文献+

视神经脊髓炎谱系病临床诊治进展

Progress in Diagnosis and Treatment of Optic Neuropathy Myelopathy
下载PDF
导出
摘要 1894年Devic等首次总结报道了17例急性横贯性脊髓炎及双侧视神经炎综合征患者,并将其命名为视神经脊髓炎(neuronyelitis optica,NMO),由此揭开了临床工作者及科研人员对NMO临床表现、发病机制、治疗等一系列的不懈探索和研究,随着研究的深入使我们对该病有着更全面的认识,从当初的NMO扩展到2007年提出NMO谱系疾病(NMO spectrum disorders,NMOSD),再到2015年对NMOSD临床诊断标准的提出。该文就近年来有关NMOSD临床诊治相关文献作一综述,旨在加深临床上对该病的认识,为更好的提高临床诊治水平。 In 1894, Devic et al. first summarized and reported 17 cases of patients with acute transverse myelitis and bilateral optic neuritis syndrome, and named it as neuromyelitis optica(NMO). This opened up clinicians and researchers have unremittingly explored and studied NMO's clinical manifestations, pathogenesis, and treatment. As the research deepens, we have a more comprehensive understanding of the disease, from the original NMO extended to the 2007 proposed NMO spectrum diseases(NMO Spectrum disorders(NMOSD), and then to the 2015 NMOSD clinical diagnostic criteria. This article reviews the relevant literature on the clinical diagnosis and treatment of NMOSD in recent years in order to deepen the clinical knowledge of the disease and to better improve the level of clinical diagnosis and treatment.
作者 张艳艳 钱伟东 ZHANG Yan-yan;QIAN Wei-dong(Resident Physician,Bengbu Medical College,Bengbu,Anhui Province,233000 China;Department of Neurology,First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui Province,233000 China)
出处 《中外医疗》 2018年第22期195-198,共4页 China & Foreign Medical Treatment
基金 蚌埠医学院研究生科研创新计划项目(Byycx1735)
关键词 视神经脊髓炎谱系病 临床诊治 综述 Optic nerve myelitis pedigrees Clinical diagnosis and treatment Review
  • 相关文献

参考文献12

二级参考文献53

  • 1Lennon VA,Wingerchuk DM,Kryzer TJ,et al.A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis.Lancet,2004,364(9451):2106-2112.
  • 2Lennon VA,Kryzer TJ,Pittock SJ,et al.IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.J Exp Med,2005,202(4):473-477.
  • 3Wingerchuk DM,Lennon VA,Lucchinetti CF,et al.The spectrum of neuromyelitis optica.Lancet Neurol,2007,6(9):805-815.
  • 4Takahashi T,Fujihara K,Nakashima I,et al.Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.Tohoku J Exp Med,2006,210(4):307-313.
  • 5Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66(10):1485-1489.
  • 6Weinshenker BG.Clinical overview of neuromyelitis optica.Rinsho Shinkeigaku,2009,49(11):894-895.
  • 7Pittock SJ,Lennon VA.Aquaporin-4 autoantibodies in a paraneoplastic context.Arch Neurol,2008,65(5):629-632.
  • 8Feng YQ,Guo N,Huang F,et al.Anti-tuberculosis treatment for Devic′s neuromyelitis optica.J Clin Neurosci,2010,17(11):1372-1377.
  • 9McDonald WI,Compston A,Edan G,et al.Recommended diagnostic criteria for multiple sclerosis:guidelines from the International Panel on the diagnosis of multiple sclerosis.Ann Neurol,2001,50(1):121-127.
  • 10Matsuoka T,Matsushita T,Kawano Y,et al.Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesionsin multiple sclerosis in Japanese.Brain,2007,130(Pt 5):1206-1223.

共引文献391

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部